The invention provides novel deazaxanthine and deazahypoxanthine compounds. The compounds may be useful in the therapy of diseases and conditions in which dipeptidylpeptidase-IV (DPP-IV) is implicated.
[EN] COMPOUNDS AS CASEIN KINASE INHIBITORS<br/>[FR] COMPOSÉS UTILISÉS EN TANT QU'INHIBITEURS DE LA CASÉINE KINASE
申请人:GRITSCIENCE BIOPHARMACEUTICALS CO LTD
公开号:WO2022127756A1
公开(公告)日:2022-06-23
Provided are casein kinase inhibitors, or pharmaceutically acceptable salts thereof. Corresponding pharmaceutical compositions, methods of synthesis, and intermediates are also provided.